TPST - Tempest Therapeutics Inc
2.39
0.080 3.347%
Share volume: 71,599
Last Updated: 03-09-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.20%
PREVIOUS CLOSE
CHG
CHG%
$2.31
0.08
0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-12-2024 | 03-27-2025 | 05-13-2025 | 08-11-2025 | 11-05-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 7.974 M | 9.582 M | 10.551 M | 13.919 M | 10.936 M | 7.966 M | 3.597 M | |
| Selling general and admin | 3.634 M | 3.745 M | 2.994 M | 3.177 M | 3.309 M | 4.095 M | 3.027 M | |
| Research and development | 4.340 M | 5.837 M | 7.557 M | 10.742 M | 7.627 M | 3.871 M | 570.000 K | |
| Total expenses | 7.974 M | 9.582 M | 10.551 M | 13.919 M | 10.936 M | 7.966 M | 3.597 M | |
| 20.17% | 10.11% | 31.92% | -21.43% | -27.16% | -54.85% | |||
| Operating income | -7.974 M | -9.582 M | -10.551 M | -13.919 M | -10.936 M | -7.966 M | -3.597 M | |
| Ebit | -7.536 M | -9.198 M | -10.227 M | -13.566 M | -10.699 M | -7.824 M | -3.511 M | |
| Pretax income | -7.904 M | -9.570 M | -10.556 M | -13.813 M | -10.860 M | -7.870 M | -3.511 M | |
| 21.08% | 10.30% | 30.85% | -21.38% | -27.53% | -55.39% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -7.904 M | -9.570 M | -10.556 M | -13.813 M | -10.860 M | -7.870 M | -3.511 M | |
| -21.08% | -10.30% | -30.85% | 21.38% | 27.53% | 55.39% |